Skip to main content
NCBI home page
Infection and Immunity logoLink to Infection and Immunity
. 1986 Sep;53(3):663–670. doi: 10.1128/iai.53.3.663-670.1986

Regulation of staphylococcal toxic shock syndrome toxin-1 and total exoprotein production by magnesium ion.

J T Mills, A W Dodel, E H Kass
PMCID: PMC260845  PMID: 3527988

Abstract

The effect of Mg2+ on in vitro production of extracellular proteins and, specifically, of toxic shock syndrome toxin-1 (TSST-1), by Staphylococcus aureus in a chemically defined medium was examined. As previously observed, the organisms did not proliferate in the absence of divalent cations. Low levels of Mg2+ (0.02 to 0.04 mM) permitted submaximal proliferation and elevated production of exoproteins. When the Mg2+ concentration was raised to 0.4 mM, multiplication was optimal and exoprotein levels were depressed. Ca2+ and Mn2+ diminished the effect of limiting Mg2+. The increased levels of exoproteins were not due to cell lysis or leakage since intracellular TSST-1 levels were not high enough to account for the increase in extracellular TSST-1 and since the intracellular enzyme, lactate dehydrogenase, was not found in culture supernatants. Cells cultured in low levels of Mg2+ remained in logarithmic growth longer than did those cultured in high concentrations of Mg2+ and, unlike the latter, produced exoproteins throughout the logarithmic growth phase. Low Mg2+ had no effect on cultures in the stationary phase, and organisms cultured in low Mg2+ recovered fully when transferred to high Mg2+. We conclude that, when cultured in medium deficient in Mg2+, S. aureus responds early in the growth cycle by increasing production of many extracellular proteins, including TSST-1.

Full text

PDF
663

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bergdoll M. S., Crass B. A., Reiser R. F., Robbins R. N., Davis J. P. A new staphylococcal enterotoxin, enterotoxin F, associated with toxic-shock-syndrome Staphylococcus aureus isolates. Lancet. 1981 May 9;1(8228):1017–1021. doi: 10.1016/s0140-6736(81)92186-3. [DOI] [PubMed] [Google Scholar]
  2. Bonventre P. F., Weckbach L., Staneck J., Schlievert P. M., Thompson M. Production of staphylococcal enterotoxin F and pyrogenic exotoxin C by Staphylococcus aureus isolates from toxic shock syndrome-associated sources. Infect Immun. 1983 Jun;40(3):1023–1029. doi: 10.1128/iai.40.3.1023-1029.1983. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Bovallius A. Production of a cholinesterase-solubilizing factor from a Cytophaga sp. by continuous cultivation. Can J Microbiol. 1969 May;15(5):429–433. doi: 10.1139/m69-075. [DOI] [PubMed] [Google Scholar]
  4. Coleman G., Brown S., Stormonth D. A. A model for the regulation of bacterial extracellular enzyme and toxin biosynthesis. J Theor Biol. 1975 Jul;52(1):143–148. doi: 10.1016/0022-5193(75)90045-4. [DOI] [PubMed] [Google Scholar]
  5. Davis B. D., Tai P. C. The mechanism of protein secretion across membranes. Nature. 1980 Jan 31;283(5746):433–438. doi: 10.1038/283433a0. [DOI] [PubMed] [Google Scholar]
  6. Ellwood D. C., Tempest D. W. Control of teichoic acid and teichuronic acid biosyntheses in chemostat cultures of Bacillus subtilis var. niger. Biochem J. 1969 Jan;111(1):1–5. doi: 10.1042/bj1110001. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Engels W., Kamps M. A., van Boven C. P. Continuous culture studies on the production of staphylocoagulase by Staphylococcus aureus. Antonie Van Leeuwenhoek. 1980;46(6):533–550. doi: 10.1007/BF00394010. [DOI] [PubMed] [Google Scholar]
  8. Heptinstall S., Archibald A. R., Baddiley J. Teichoic acids and membrane function in bacteria. Nature. 1970 Feb 7;225(5232):519–521. doi: 10.1038/225519a0. [DOI] [PubMed] [Google Scholar]
  9. Igarashi H., Fujikawa H., Usami H., Kawabata S., Morita T. Purification and characterization of Staphylococcus aureus FRI 1169 and 587 toxic shock syndrome exotoxins. Infect Immun. 1984 Apr;44(1):175–181. doi: 10.1128/iai.44.1.175-181.1984. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. LOWRY O. H., ROSEBROUGH N. J., FARR A. L., RANDALL R. J. Protein measurement with the Folin phenol reagent. J Biol Chem. 1951 Nov;193(1):265–275. [PubMed] [Google Scholar]
  11. Martin J. F., Demain A. L. Control of antibiotic biosynthesis. Microbiol Rev. 1980 Jun;44(2):230–251. doi: 10.1128/mr.44.2.230-251.1980. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Mills J. T., Parsonnet J., Tsai Y. C., Kendrick M., Hickman R. K., Kaśs E. H. Control of production of toxic-shock-syndrome toxin-1 (TSST-1) by magnesium ion. J Infect Dis. 1985 Jun;151(6):1158–1161. doi: 10.1093/infdis/151.6.1158. [DOI] [PubMed] [Google Scholar]
  13. Parsonnet J., Hickman R. K., Eardley D. D., Pier G. B. Induction of human interleukin-1 by toxic-shock-syndrome toxin-1. J Infect Dis. 1985 Mar;151(3):514–522. doi: 10.1093/infdis/151.3.514. [DOI] [PubMed] [Google Scholar]
  14. Parsonnet J., Mills J. T., Gillis Z. A., Pier G. B. Competitive, enzyme-linked immunosorbent assay for toxic shock syndrome toxin 1. J Clin Microbiol. 1985 Jul;22(1):26–31. doi: 10.1128/jcm.22.1.26-31.1985. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Reeves M. W., Pine L., Feeley J. C., Wells D. E. Presence of toxic shock toxin in toxic shock and other clinical strains of Staphylococcus aureus. Infect Immun. 1984 Nov;46(2):590–597. doi: 10.1128/iai.46.2.590-597.1984. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Schlievert P. M. Effect of magnesium on production of toxic-shock-syndrome toxin-1 by Staphylococcus aureus. J Infect Dis. 1985 Sep;152(3):618–620. doi: 10.1093/infdis/152.3.618. [DOI] [PubMed] [Google Scholar]
  17. Schlievert P. M., Shands K. N., Dan B. B., Schmid G. P., Nishimura R. D. Identification and characterization of an exotoxin from Staphylococcus aureus associated with toxic-shock syndrome. J Infect Dis. 1981 Apr;143(4):509–516. doi: 10.1093/infdis/143.4.509. [DOI] [PubMed] [Google Scholar]
  18. Todd J. K., Franco-Buff A., Lawellin D. W., Vasil M. L. Phenotypic distinctiveness of Staphylococcus aureus strains associated with toxic shock syndrome. Infect Immun. 1984 Aug;45(2):339–344. doi: 10.1128/iai.45.2.339-344.1984. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. de Azavedo J. C., Arbuthnott J. P. Toxicity of staphylococcal toxic shock syndrome toxin 1 in rabbits. Infect Immun. 1984 Nov;46(2):314–317. doi: 10.1128/iai.46.2.314-317.1984. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. van de Rijn I., Kessler R. E. Growth characteristics of group A streptococci in a new chemically defined medium. Infect Immun. 1980 Feb;27(2):444–448. doi: 10.1128/iai.27.2.444-448.1980. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Infection and Immunity are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES